We recently read with interest the recent meta-analysis performed by Agarwal et al.
Reply
We appreciate the interest expressed by Dr. Freund and colleagues in our recent meta-analysis describing transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events attributed to paradoxical thromboembolism (1) . We reviewed the study published by the authors in 2009 and agree that this study meets the criteria for inclusion in our meta-analysis and should have been included (2) . The conclusions reached by the authors were very similar to those reported in our meta-analysis.
The study in question represents a well-characterized cohort of patients who had a relatively long follow-up. We analyzed our data again after, including this study, and report that there were no significant changes in the results and conclusions reached in our study. The pooled incidence rate of recurrent neurological events was calculated as 0.78%/year as compared with 0.76%/year reported in our original meta-analysis. This difference is not statistically significant. Besides this, the other subgroup analyses reported in our original manuscript, including the impact of residual shunting on recurrent events, remains unchanged.
